Sigyn Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $910 | $0 | $500 |
| FY2020 | $594.9K | $694.1K | $84.4K |
| FY2021 | $974.8K | $710.3K | $341.0K |
| FY2022 | $2.2M | $332.9K | $8.4K |
| FY2023 | $3.7M | $321.8K | $11.7K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $910 | $0 | $500 |
| FY2020 | $594.9K | $694.1K | $84.4K |
| FY2021 | $974.8K | $710.3K | $341.0K |
| FY2022 | $2.2M | $332.9K | $8.4K |
| FY2023 | $3.7M | $321.8K | $11.7K |